Please use this identifier to cite or link to this item:
Title: Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency.
Author: Chaccour, Carlos
Hammann, Felix
Ramón García, Santiago
Rabinovich, Regina
Keywords: COVID-19
Salut pública
Administració de medicaments
Public health
Administration of drugs
Issue Date: 16-Apr-2020
Publisher: The American Society of Tropical Medicine and Hygiene
Abstract: Ivermectin is a widely used drug for the treatment and control of several neglected tropical diseases.The drug has an excellent safety profile, with more than 2.5 billion doses distributed in the last 30 years, and its potential to reduce malaria transmission by killing mosquitoes is under evaluation in several trials around the world. Ivermectin inhibits the in vitro replication of some positive, single-stranded RNA viruses, namely, dengue virus (DNV), Zika virus, yellow fever virus, and others.
Note: Reproducció del document publicat a:
It is part of: American Journal Of Tropical Medicine And Hygiene , 2020
Related resource:
ISSN: 0002-9637
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Chaccour_C_Am_J_Trop_Med_Hyg_2020.pdf65.18 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons